An MS patient loses trust when she finds out her doctor is paid by drug companies.

摘要

Last year, four years after showing initial symptoms of multiple sclerosis (MS), I walked out the door of one neurologist's office and, after several months of searching, switched to a different doctor. It was the final act in a series of events that had gradually eroded my trust in the first neurologist's judgment, which I believe was colored by his financial relationships with drug companies who manufacture and market medicines for MS patients.I had started to see this neurologist not long after I experienced my first MS symptom: the sudden onset of visual distortion in my right eye. I suspected I needed glasses, but when it was determined that I had 20/20 vision, I was referred to a neuro-ophthalmologist and, finally, to the neurologist in question.